Universal-Beteiligungs- und Servicegesellschaft
RLAY icon

Universal-Beteiligungs- und Servicegesellschaft’s Relay Therapeutics RLAY Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Sell
11,626
-2,243
-16% -$32.6K ﹤0.01% 2011
2026
Q1 		$138K Buy
+13,869
New +$124K ﹤0.01% 2009

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's RLAY Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft reduced its Relay Therapeutics (RLAY) stake by 16% in Q2 2026, selling an estimated $32.6K and leaving 11,626 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #2011.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in RLAY in Q1 2026 and has held it in 2 quarters since. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 11,626 shares of Relay Therapeutics worth $218K as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft sold 2,243 Relay Therapeutics shares in Q2 2026, an estimated $32.6K.
  • Relay Therapeutics made up ﹤0.01% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #2011 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Relay Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.